Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06079333
Title NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study) (NEO-ATACT)
Acronym NEO-ATACT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Leiden University Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Additional content available in CKB BOOST